NYU Langone Health
NYU Langone Health is an academic medical center located in New York City, New York, United States. The health system consists of the NYU Grossman School of Medicine and NYU Grossman Long Island School of Medicine, both part of New York University (NYU), and more than 300 locations throughout the New York City Region and Florida, including six inpatient facilities: Tisch Hospital; Kimmel Pavilion; NYU Langone Orthopedic Hospital; Hassenfeld Children's Hospital; NYU Langone Hospital – Brooklyn; and NYU Langone Hospital – Long Island.[1][2] It is also home to Rusk Rehabilitation.[3] NYU Langone Health is one of the largest healthcare systems in the Northeast, with more than 49,000 employees.[4]
NYU Langone Health
550 First Avenue,
New York, New York, United States
Private
NYU Langone Health System
nearly 2000 (total of all hospitals combined)
1841
NYU Langone Health is ranked the #1 comprehensive academic medical center and the #1 ambulatory care system for quality and safety in the U.S. by Vizient, Inc., the nation's largest healthcare performance improvement organization.[5] NYU Langone is among the best hospitals in the U.S., according to "U.S. News & World Report’s" 2023–24 “Best Hospitals Honor Roll,” earning top 10 rankings in 10 specialties. NYU Grossman School of Medicine is ranked #10 in the nation on U.S. News & World Report’s 2023–24 list of “Best Graduate Schools for Research.”[6][7] Rusk Rehabilitation is ranked the #1 rehabilitation program in New York State and one of the top five in the country by U.S. News & World Report. The Centers for Medicare & Medicaid Services has awarded the institution a five-star rating.[8][9] NYU Langone Health's four hospitals have all earned the Magnet designation for excellence in nursing and quality patient care from the American Nurses Credentialing Center, an honor achieved by only 9.4% of hospitals in the U.S.[10]
History[edit]
NYU Langone Health[edit]
NYU Langone Health’s precursor, the Medical College of New York University, was founded in 1841.[11] Among the college's six original faculty members were renowned surgeon Valentine Mott, MD, and John Revere, MD, the youngest son of patriot Paul Revere.[11][12]
In 1898, the Medical College consolidated with Bellevue Hospital Medical College, forming University and Bellevue Hospital Medical College of New York University, established at 26th Street and First Avenue in New York City, New York.[11][13] This began NYU Langone Health's long relationship with its primary teaching affiliate, NYC Health + Hospitals/Bellevue, America's oldest public hospital, founded in 1736.[14]
NYU Langone Health's first hospital, established in 1948 as University Hospital on lower Broadway, was created through a merger of the New York Post-Graduate Hospital and the New York Skin and Cancer Hospital.[11] In 1963, a newly-acquired site in midtown Manhattan—bounded by First Avenue and the Franklin D. Roosevelt East River Drive, between 30th and 34th Streets—became the home of University Hospital's new 18-story building, which housed expanded research labs.[15][16]
University Hospital was renamed Tisch Hospital in 1989 in gratitude to Laurence A. and Preston Robert Tisch and their families, benefactors of New York University.[16]
In 2008, NYU Medical Center, as the institution was then known, was renamed the NYU Elaine A. and Kenneth G. Langone Medical Center in honor of its chair of the Board of Trustees and his wife, whose total unrestricted gifts of $200 million represent the largest donation in the institution's history.[17][18] In 2017, NYU Langone Medical Center was renamed NYU Langone Health.[19]
NYU Langone Health's long-time affiliate, the Hospital for Joint Diseases, now known as NYU Langone Orthopedic Hospital, was the first hospital to merge with the institution in 2006, becoming its dedicated orthopedic hospital.[20][21][22]
In 2016, NYU Langone Health acquired Lutheran Medical Center, a 444-bed hospital in southwest Brooklyn, renaming it NYU Langone Hospital—Brooklyn.[23][24][14]
In 2019, NYU Langone Health acquired Winthrop University Hospital, a 591-bed hospital in Mineola on Long Island, renaming it NYU Langone Hospital—Long Island.[25][1][26]
In 2023, NYU Langone Health’s revenue was more than $12 billion, including more than $4.9 billion in philanthropy since 2007.
Centers and institutes[edit]
Laura and Isaac Perlmutter Cancer Center[edit]
Laura and Isaac Perlmutter Cancer Center is one of 56 cancer centers in the U.S. designated a Comprehensive Cancer Center by the National Cancer Institute, part of the National Institutes of Health.[72] The designation signifies a commitment to research, clinical trials, education and training, community outreach, and the development of effective approaches to cancer prevention, diagnosis, and treatment.[73] Perlmutter Cancer Center was ranked among the top 25 hospitals in the US for cancer on the 2023–2024 U.S. News & World Report "Best Hospitals" Honor Roll.The publication also rated Perlmutter Cancer Center as "high performing" for these procedures and cancer conditions for adults: colon cancer surgery, lung cancer surgery, ovarian cancer surgery, prostate cancer surgery, uterine cancer surgery, and leukemia, lymphoma, and myeloma treatment.[74] The Center pursues research in cancer genome dynamics, cancer cell biology, melanoma, tumor immunology, and epidemiology and cancer control.[75] The center's Blood and Marrow Transplant Program is certified by the Foundation for the Accreditation of Cellular Therapy to perform autologous and allogeneic transplants for adult patients, and autologous transplants for pediatric patients.[75] Dermatologists at NYU Langone Health were the first to develop criteria for early detection of melanoma.[76]
Rusk Rehabilitation[edit]
Rusk Rehabilitation is ranked the #1 rehabilitation program in New York State and one of the top five in the country by U.S. News & World Report.[77] At 27 inpatient and outpatient locations, its clinicians treat a range of adult and pediatric conditions, including brain injury, spinal cord injury, cancer, cardiac and pulmonary diseases, chronic neurological diseases, orthopedic and musculoskeletal diseases, limb loss, and stroke.[78]
Rusk Rehabilitation was established in 1948 as the first comprehensive medical training program in rehabilitation in the world.[79] Its founder, Howard A. Rusk, MD, chair of the Department of Physical Medicine and Rehabilitation at what is now NYU Grossman School of Medicine, is considered the father of comprehensive rehabilitation medicine.[79] He drew on his experience treating wounded World War II veterans to develop a philosophy of caring for the patient as whole person.[79] Rusk Rehabilitation's inpatient programs at Tisch Hospital and NYU Langone Orthopedic Hospital are accredited by the Commission on Accreditation of Rehabilitation Facilities.[80]
Vilcek Institute of Graduate Biomedical Sciences[edit]
In 2020, the institute, which offers programs in the basic medical sciences leading to a Ph.D. and M.D./Ph.D., was named in honor of Jan T. Vilcek, MD, PhD, a professor emeritus of microbiology and trustee of NYU Langone Health.[81] Vilcek codeveloped the monoclonal antibody that is the basis for Remicade, a drug widely used to treat certain chronic inflammatory disorders.[81]
NYU Langone Transplant Institute[edit]
The NYU Langone Transplant Institute is directed by Robert A. Montgomery, M.D., D.Phil. the H. Leon Pachter, M.D. Professor of Surgery and chair of the Department of Surgery.[82][81] The institute performs heart, lung, adult and pediatric kidney, heart-lung, kidney-pancreas, liver, and pancreas transplants.[83] According to the Scientific Registry of Transplant Recipients (SRTR), the kidney and heart transplant programs have a one-year survival rate of 100%.[83] In 2022, a team of surgeons performed the first successful triple transplant for heart, lungs, and kidney in the Northeast.[84]
In 2023, surgeons led by Eduardo D. Rodriguez, M.D., D.D.S., the Helen L. Kimmel Professor of Reconstructive Plastic Surgery and chair of NYU Langone Health’s Hansjörg Wyss Department of Plastic Surgery, performed the world’s first whole-eye and partial-face transplant.[85]
Clinical milestones[edit]
Two alumni of NYU Grossman School of Medicine, Jonas Salk, M.D., and Albert Sabin, M.D., developed vaccines for polio, approved in the U.S. 1955.[86]
Saul Krugman, M.D., chair of the Department of Pediatrics at NYU Grossman School of Medicine from 1960 to 1974, conducted research that led to vaccines for measles, rubella, and hepatitis B.[87]
In 1948, Howard A. Rusk, M.D., drew on his experience caring for wounded World War II veterans to establish the world's first comprehensive training program in rehabilitation medicine.[88]
In 1981, a group of NYU Langone Health's physicians at NYC Health + Hospitals/Bellevue coauthored the first paper published in a medical journal, The Lancet, linking HIV/AIDS to cases of Kaposi's sarcoma, a previously rare skin cancer that would become an AIDS-defining illness.[89][90]
In 2001, Charles S. Hirsch, M.D., chair of NYU Langone Health's Department of Forensic Medicine and Chief Medical Examiner of the City of New York, coordinated the largest forensic investigation in history, cataloguing some 22,000 individual human remains and identifying about 60% of the 2,753 victims of the World Trade Center attack.[91]
In 2015, surgeons led by Eduardo D. Rodriguez, M.D., D.D.S., the Helen L. Kimmel Professor of Reconstructive Plastic Surgery and chair of NYU Langone Health's Hansjörg Wyss Department of Plastic Surgery, performed the most extensive face transplant to date, followed in 2020 by the world's first successful face and double hand transplant.[92]
In 2021, surgeons led by Robert A. Montgomery, M.D., D.Phil., director of the NYU Langone Transplant Institute, performed the first investigational transplant of a kidney grown in a genetically altered pig to a brain-dead person whose bodily functions were sustained by mechanical support.[93] In separate investigational procedures performed in June and July 2022, surgeons led by Dr. Robert Montgomery successfully transplanted hearts from genetically altered pigs into brain-dead patients, marking the latest advance toward addressing the nationwide organ shortage and developing a clinical protocol that would provide an alternative supply of organs for people with life-threatening heart disease.[94]
Institutional milestones[edit]
On October 29, 2012, Hurricane Sandy, the worst storm to strike New York City in two centuries, flooded NYU Langone Health's midtown Manhattan campus with more than 15 million gallons of water overflowing from the East River.[95] Hurricane Sandy inflicted more than $1 billion of damage to the institution's infrastructure, forcing a temporary shutdown.[96] Within 13 hours, some 1,000 medical and professional personnel safely evacuated 322 patients and transferred them to 14 other hospitals. On December 27, major clinical units reopened, 59 days after the storm.[97] U.S. Senator Charles Schumer helped secure more than $150 million of federal aid to repair and replace damaged facilities.[98] Nurse Menchu de Luna Sanchez, who devised a plan to safely evacuate 20 at-risk infants from Tisch Hospital's neonatal intensive care unit, was one of the honored guests at President Obama's State of the Union Address on February 12, 2013.[99] Lighting the way with flashlights and iPhones, clinicians carried the infants down eight flights of stairs and transferred them to local hospitals.[100]
In 2021, NYU Langone Health was selected by the National Institutes of Health (NIH) to be the Clinical Science Core of the Researching COVID to Enhance Recovery (RECOVER) Initiative.[101] RECOVER is a project aimed at understanding the long-term effects of COVID-19 to help develop new approaches to diagnosis and treatment.[102] As part of the research, NYU Langone received a parent award of more than $450 million. The institution is charged with leading and integrating the research activities of 35 institutions and 100 researchers nationwide, to which it will make sub-awards.[101] RECOVER will study adults, children, and electronic health records to examine how many people are affected by COVID in the long term, which treatments contribute to recovery, and why some patients are vulnerable to lingering symptoms while others are not.[101]